Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04CFP
|
||||
Former ID |
DNC011111
|
||||
Drug Name |
5-[4-(Pyridin-4-ylmethyl)phenyl]-1H-indole
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [531085] | ||
Structure |
Download2D MOL |
||||
Formula |
C20H16N2
|
||||
Canonical SMILES |
C1=CC(=CC=C1CC2=CC=NC=C2)C3=CC4=C(C=C3)NC=C4
|
||||
InChI |
1S/C20H16N2/c1-3-17(18-5-6-20-19(14-18)9-12-22-20)4-2-15(1)13-16-7-10-21-11-8-16/h1-12,14,22H,13H2
|
||||
InChIKey |
VVBPUVXDCLUNKF-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 17 alpha-hydroxylase-C17, 20-lyase | Target Info | Inhibitor | [531085] | |
Cytochrome P450 11B1, mitochondrial | Target Info | Inhibitor | [531085] | ||
PathWhiz Pathway | Androgen and Estrogen Metabolism | ||||
SteroidogenesisPW000141:Steroidogenesis | |||||
WikiPathways | Metapathway biotransformation | ||||
Steroid Biosynthesis | |||||
Oxidation by Cytochrome P450 | |||||
Metabolism of steroid hormones and vitamin D | |||||
Glucocorticoid & Mineralcorticoid Metabolism | |||||
Prostate Cancer | |||||
Phase 1 - Functionalization of compoundsWP702:Metapathway biotransformation | |||||
Corticotropin-releasing hormone | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.